Thrombopoietin Directly and Potently Stimulates Multilineage Growth and Progenitor Cell Expansion from Primitive (CD34+ CD38-) Human Bone Marrow Progenitor Cells: Distinct and Key Interactions with the Ligands for C-kit and Flt3, and Inhibitory...
Overview
Authors
Affiliations
Thrombopoietin (Tpo) is a primary regulator of megakaryocyte and platelet production. However, studies in c-mpl-deficient mice suggest that Tpo might also play an important role in early hemopoiesis. Here, the direct ability of Tpo to stimulate stroma-independent growth, multilineage differentiation, and progenitor cell expansion from single primitive CD34+ CD38- human bone marrow cells was investigated. Tpo alone stimulated limited clonal growth, but synergized with c-kit ligand (KL), flt3 ligand (FL), or IL-3 to potently enhance clonogenic growth. Whereas KL and FL in combination stimulated the clonal growth of only 3% of CD34+ CD38- cells, 40% of CD34+ CD38- cells were recruited by KL+FL+Tpo, demonstrating that Tpo promotes the growth of a high fraction of CD34+ CD38- progenitor cells. Additional cytokines (IL-3, IL-6, and erythropoietin (Epo)) did not significantly enhance clonal growth above that observed in response to KL+FL+Tpo. In contrast, Tpo enhanced clonogenic growth in response to KL+FL+IL-3+IL-6+Epo by as much as 80%, implicating a key role for this cytokine in early hemopoiesis. Importantly, we also demonstrate that the majority of Tpo-recruited CD34+ CD38- progenitor cells have a multilineage differentiation potential, and that Tpo promotes prolonged expansion of multipotent progenitors. Specifically, whereas progenitor cells were reduced in cultures containing only KL+FL, addition of Tpo resulted in 40-fold expansion of multipotent progenitors following a 14-day incubation. Finally, we identified inhibitors of Tpo-induced progenitor cell growth, in that TGF-beta as well as TNF-alpha almost completely abrogated the growth of CD34+ CD38- progenitor cells in response to Tpo alone as well as KL+FL+Tpo.
Holmes-Hampton G, Kumar V, Biswas S, Stone S, Sharma N, Legesse B Sci Rep. 2023; 13(1):15211.
PMID: 37709916 PMC: 10502090. DOI: 10.1038/s41598-023-42443-0.
Aydin S, Dellacasa C, Manetta S, Giaccone L, Godio L, Iovino G Ther Adv Hematol. 2020; 11:2040620720961910.
PMID: 33194161 PMC: 7594218. DOI: 10.1177/2040620720961910.
Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia.
Saulep-Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C Leukemia. 2014; 28(10):2005-15.
PMID: 24721775 PMC: 4100939. DOI: 10.1038/leu.2014.105.
Sun H, Tsai Y, Nowak I, Liesveld J, Chen Y Stem Cell Res. 2012; 9(2):77-86.
PMID: 22683680 PMC: 3412938. DOI: 10.1016/j.scr.2012.05.001.
Bramono D, Rider D, Murali S, Nurcombe V, Cool S Pharm Res. 2010; 28(6):1385-94.
PMID: 21184148 DOI: 10.1007/s11095-010-0352-y.